https://www.pharmacytimes.com/view/fda-approves-nirsevimab-alip-to-prevent-rsv-in-infants-toddlers
0
0
7/17/23 at 7:58pm
Organization
Pharmacytimes.com
31 words
0
Comments
The approval marks the first monoclonal antibody approved to protect all infants through their first respiratory syncytial virus season.
You are the first to view
Create an account
or login to join the discussion